Tigecycline- A Novel Expanded Spectrum Antibiotic for the treatment of serious infections

Jose, J and Jimmy, B and Saravu, Kavitha (2007) Tigecycline- A Novel Expanded Spectrum Antibiotic for the treatment of serious infections. Journal of Clinical and Diagnostic Research. , 1 (2). pp. 181-184. ISSN 0973-709x

[img] PDF
tigecycline_jcdr_pdf.pdf - Published Version
Restricted to Registered users only

Download (210kB) | Request a copy


Resistance to presently available antibiotics is increasing at an alarming rate, and the same proves to be a major hurdle in the treatment of infections, especially serious infections, where organisms with a wide range of antibacterial resistance are frequently present. The drug discovery sector is concentrating on developing antibiotics with a broader antibiotic coverage to overcome the existing resistance mechanisms displayed by organisms. Tigecycline is a member of a new class of antibiotics named glycylcyclines. This is an antibiotic class related to tetracyclines and has the above mentioned properties. This new drug has been shown to confer broad antibiotic coverage and prove effective against many species of multidrugresistant organisms. The drug was approved by the US Food and Drug Administration for the treatment of complicated skin and skin structure infections and complicated intra-abdominal infections in June 2005. Tigecycline has been efficacious and well tolerated in clinical studies. The drug is not currently available in India. It will be a welcome addition to the current armamentarium for the treatment of serious infections.

Item Type: Article
Uncontrolled Keywords: Tigecycline, expanded spectrum antibiotic, glycylcyclines, serious infections.
Subjects: Medicine > KMC Manipal > Medicine
Pharmacy > MCOPS Manipal > Pharmacy Practice
Depositing User: KMC Manipal
Date Deposited: 19 Jun 2012 04:57
Last Modified: 19 Jun 2012 04:57
URI: http://eprints.manipal.edu/id/eprint/76690

Actions (login required)

View Item View Item